Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

Weight-loss jabs linked to ‘severe’ stomach problems – study

Researchers said instances were ‘rare’ but hundreds of thousands of people could still be affected due to the drugs’ popularity globally.

The Independent UK

Weight loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says

Weight loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says

The drugs, although not officially approved for use in weight loss, have been touted as a “miracle” treatments for obesity.

Weight-loss drugs like Ozempic have so much promise a major bank is telling investors to short junk food stocks

Weight-loss drugs like Ozempic have so much promise a major bank is telling investors to short junk food stocks

Barclays strategists expect "disruption into a number of industries," thanks to drugs like Novo Nordisk's Ozempic and Wegovy.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Wegovy weight-loss jab 'significantly' improves blood sugar in diabetics

Hailed as potential ‘game changer’ in tackling obesity, Semaglutide can also help those with type 2 diabetes

The Independent UK

Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests

The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.

Weight loss jab ‘significantly’ improves blood sugar in diabetics, study finds

Researchers said semaglutide’s effectiveness in treating type 2 diabetes has been shown in some trials, but long-term data is ‘lacking’.

The Independent UK

These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs

After a run, stocks can offer a new buying opportunity with a pullback to the 50-day line. Novo Nordisk and 4 S&P 500 stocks have done that.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Stock Market Falls Into Correction On Hawkish Fed: Weekly Review

Stock Market Falls Into Correction On Hawkish Fed: Weekly Review

A market correction has taken hold as Treasury yields surged to long-term highs on a hawkish Fed outlook.

Investors Business Daily

Novo Nordisk Stock Skids After FDA Inspection Turns Up Problematic Bacteria In Key Plant

Novo Nordisk Stock Skids After FDA Inspection Turns Up Problematic Bacteria In Key Plant

Novo Nordisk found "objectionable" bacteria in several batches of semaglutide, according to an FDA report. Novo Nordisk stock fell Thursday.

Investors Business Daily

Denmark's Novo Nordisk and South Africa's Aspen sign a deal to produce insulin for African patients

Denmark's Novo Nordisk and South Africa's Aspen sign a deal to produce insulin for African patients

Danish pharmaceutical company Novo Nordisk has signed a deal with South Africa’s Aspen Pharmacare to produce human insulin specifically for diabetes patients in Africa where there is a dire need for the life-saving treatment

The Independent UK

3 Biotechs with Massive Growth Potential

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Novo Nordisk stock skidded Monday on reports an inspection turned up "objectionable conditions" at a diabetes and weight-loss drugs manufacturing plant.

Investors Business Daily

Wegovy: the slimming drug that keeps Denmark’s economy growing

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

The Guardian - UK

Dow Jones Futures Fall As Market Rally Nears Big Test; Meta Leads 4 Stocks Near Buy Points

Dow Jones Futures Fall As Market Rally Nears Big Test; Meta Leads 4 Stocks Near Buy Points

The Nasdaq fell below its 50-day line with the market rally facing a big test. Meta is flirting with a buy point.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Ozempic, weight-loss ‘wonder drug’, under scrutiny amid suicide risk claims

Ozempic has not shown increased risk of suicidal ideation in trials, but some users say it harmed their mental health.

The Conversation

Wegovy has arrived in the UK: the story of the weight-loss jab so far

In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a “gamechanger”. Gamechanger is a word used far too often by journalists to describe things that are, frankly, mundane. This time, though, the word seems apt.

Novo Nordisk beats LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug Wegovy to the U.K.

The Danish pharma giant overtook French luxury conglomerate LVMH as the most valuable European company, which held the title since 2021.

Danish pharma group becomes Europe's most valuable firm after UK weight loss drug launch

Danish drugmaker Novo Nordisk is now Europe's largest company in market capitalisation, ahead of French luxury giant LVMH. This follows the UK launch of Wegovy, a weight loss drug that cuts appetite and cravings. Tens of thousands of people have already signed up to waiting lists for the treatment. Also…

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Wegovy maker Novo Nordisk becomes Europe’s most valuable firm

Launch of weight-loss drug in UK helps Danish firm to market value of $428bn

The Independent UK

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

Evening Standard

Wegovy weight-loss jab to launch in the UK

The drug is in short supply but a proportion has been allocated to specialist NHS services

The history of weight loss drugs

"It is no wonder demand for weight-loss drugs continues to soar"

Novo Nordisk: the pharma giant making Denmark rich from US obesity epidemic

Soaring demand for two weight-loss wonder-drugs developed by a Danish pharmaceutical company is having a knock-on effect on the whole of Denmark’s economy.

Investors Business Daily

How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment

Novo Nordisk said Friday its obesity treatment, Wegovy, reduced heart-failure symptoms. But Novo Nordisk stock remained flat.

Investors Business Daily

Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, Novo

Prescriptions of weight-loss and diabetes drugs have rocketed this year, giving Novo Nordisk stock and Eli Lilly stock more room to run.

1 … 12 13 14 15

People

Steven AdamsAfter

Elizabeth Anderson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

The Independent

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

250,298 stories

104,190 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play